TY  - GEN
AU  - Chen,Lindi
AU  - Pastorino,Fabio
AU  - Berry,Philip
AU  - Bonner,Jennifer
AU  - Kirk,Calum
AU  - Wood,Katrina M
AU  - Thomas,Huw D
AU  - Zhao,Yan
AU  - Daga,Antonio
AU  - Veal,Gareth J
AU  - Lunec,John
AU  - Newell,David R
AU  - Ponzoni,Mirco
AU  - Tweddle,Deborah A
TI  - Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
SN  - 1097-0215
PY  - 2019///1008
KW  - Animals
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Drug Screening Assays, Antitumor
KW  - Drug Synergism
KW  - Humans
KW  - Mice
KW  - Neuroblastoma
KW  - drug therapy
KW  - Prodrugs
KW  - pharmacokinetics
KW  - Proto-Oncogene Proteins c-mdm2
KW  - antagonists & inhibitors
KW  - Pyrrolidines
KW  - Random Allocation
KW  - Temozolomide
KW  - administration & dosage
KW  - Tumor Suppressor Protein p53
KW  - genetics
KW  - Xenograft Model Antitumor Assays
KW  - para-Aminobenzoates
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1002/ijc.32058
ER  -